Insulin: the INSULIN Act
What they say
In a July op-ed she says she joined three Senate colleagues this spring to introduce the INSULIN Act, and that it passed the Senate health committee by a bipartisan vote of 17 to 5.
“Stories like Bek’s are why I joined three Senate colleagues this spring to introduce the bipartisan INSULIN Act.”
What the record shows ·
S. 4189, the INSULIN Act of 2026, was introduced on March 25, 2026 by Jeanne Shaheen for herself, Collins, Raphael Warnock and John Kennedy, with eight more original cosponsors; Collins is named first. The Health, Education, Labor and Pensions Committee ordered it reported with a substitute on July 22, 2026; the committee's own record of that session lists it as agreed to by roll call vote, 17 to 5. It was placed on the Senate calendar on August 7. The reported text keeps a cap of $35 per 30-day supply for private and employer coverage. It has not passed the Senate.
Limit: The introduction, the committee's approval and its 17-to-5 tally are on the record, and Congress.gov lists Shaheen as the sponsor, which is what "joined three Senate colleagues" says. The committee's page does not list each senator's vote, but the tally shows both parties voted yes: neither party has 17 seats on the committee (the Senate's roster lists 12 Republicans and 11 Democrats). A bill reported from committee is not law.